2012-10-04 07:54:20 - New Pharmaceuticals market report from Global Markets Direct: "Rhino-Conjunctivitis - Pipeline Review, H2 2012"

Global Markets Direct's, 'Rhino-Conjunctivitis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Rhino-Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rhino-Conjunctivitis. Rhino-Conjunctivitis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Full Report

Details at
- www.fastmr.com/prod/468460_rhinoconjunctivitis_pipeline_review_h ..


Scope

* A snapshot of the global therapeutic scenario for Rhino-Conjunctivitis.
* A review of the Rhino-Conjunctivitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Rhino-Conjunctivitis pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Rhino-Conjunctivitis.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Rhino-Conjunctivitis pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Rhino-Conjunctivitis Overview
Therapeutics Development
An Overview of Pipeline Products for Rhino-Conjunctivitis
Rhino-Conjunctivitis Therapeutics under Development by Companies
Rhino-Conjunctivitis Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Rhino-Conjunctivitis Therapeutics - Products under Development by Companies
Rhino-Conjunctivitis Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Rhino-Conjunctivitis Therapeutics Development
ALK-Abello A/S
Stallergenes S.A.
Cytos Biotechnology AG
Allergopharma Joachim Ganzer KG
Laboratorios LETI S.L.
Rhino-Conjunctivitis - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
CYT-003-QbG10 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
rBet v1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Olea Europaea Pollen Extract - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Modified Allergen Extract - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MK-7243 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AL-0704rP - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Mutaflor - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MK-3641 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Depigoid Birch - Drug Profile
Product Description
Mechanism of Action
R&D Progress
gpASIT + TM - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ALK Birch Pollen Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AL-0701rP - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Osiris - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Recombinant Birch Pollen Allergen - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Rhino-Conjunctivitis Therapeutics - Drug Profile Updates
Rhino-Conjunctivitis Therapeutics - Dormant Products
Rhino-Conjunctivitis - Product Development Milestones
Featured News & Press Releases
Mar 21, 2012: Paladin Labs Receives Canadian Approval For Oralair
Nov 28, 2011: Allergy Therapeutics Submits Complete Response To PEI In Germany And Clinical Study Protocol To FDA
May 24, 2011: Paladin Labs Files New Drug Submission For Oralair
Apr 18, 2011: ALK To Receive GRAZAX Reimbursement In Denmark
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Rhino-Conjunctivitis, H2 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468460&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.